相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AJE 润色服务限时 8 折起,权威机构信任 15+ 年Cytoscape 教程来了!快速实现顶刊同款通路网络图五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
-20℃
- 保质期:
12 months
- 英文名:
InVivoMAb Anti-Human CD79b & CD3 Bispecific Antibody (BS001)
- 供应商:
武汉益普生物科技有限公司
- 规格:
100μg/1mg
| 规格: | 100μg | 产品价格: | ¥3378.0 |
|---|---|---|---|
| 规格: | 1mg | 产品价格: | ¥11588.0 |
| 产品名称 | InVivoMAb Anti-Human CD79b & CD3 Bispecific Antibody (BS001) |
| 货号 | HW431010 |
| 描述 | InVivoMAb Anti-Human CD79b & CD3 Bispecific Antibody (BS001) [BS001] ( HW431010 ) is a human monoclonal antibody detecting B-cell-specific glycoprotein B29 in FuncS . Suitable for Human . |
| 反应种属 | Human |
| 应用实验 | FuncS |
| 宿主/表达体系 | Human |
| 靶点 | B-cell-specific glycoprotein B29, CD79B, B-cell antigen receptor complex-associated protein beta chain, Ig-beta, B29, Immunoglobulin-associated B29 protein, IGB, CD79b, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain |
| 基因号 | P40259 & P07766 |
| 状态 | Liquid |
| 纯度 | >95% as determined by SDS-PAGE. |
| 储存温度 | -20℃ |

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验T-Cell Activation Using mAb to CD3
splenic T-cells and human peripheral T cells stimulated via CD3. Critical parameters include cell density, antibody titer and activation kinetics. Materials 1X sterile PBS Anti-mouse CD3e, Clone 145-2C11 (Functional Grade, Cat. No. 16
[欢迎下载]:Antibody Engineering: Methods and Protocols
of Human Immunoglobulin Genes 7 Antibody Humanization by CDR Grafting 8 Selection of Human Antibodies from Phage Display Libraries 9 Production of Human Single-Chain Antibodies by Ribosome Display 10 Production of Human Antibodies from Transgenic Mice
实验原理 Dynabeads® CD3⁄CD28 CTS™ offer a simple method for isolation, activation and expansion of human T cells. Firstly, CD3 T cells are separated and concentrated from the apheresis product by magnetic cell separation
技术资料暂无技术资料 索取技术资料










